NM_031427.4:c.*32T>C
Variant names:
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_ModerateBP6_Very_Strong
The NM_031427.4(DNAL1):c.*32T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000198 in 1,548,398 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00018 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00020 ( 0 hom. )
Consequence
DNAL1
NM_031427.4 3_prime_UTR
NM_031427.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.58
Publications
0 publications found
Genes affected
DNAL1 (HGNC:23247): (dynein axonemal light chain 1) This gene encodes an axonemal dynein light chain which functions as a component of the outer dynein arms complex. This complex acts as the molecular motor that provides the force to move cilia in an ATP-dependent manner. The encoded protein is expressed in tissues with motile cilia or flagella and may be involved in the movement of sperm flagella. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Jan 2011]
DNAL1 Gene-Disease associations (from GenCC):
- primary ciliary dyskinesia 16Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: PanelApp Australia, Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae)
- primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.38).
BP6
Variant 14-73695974-T-C is Benign according to our data. Variant chr14-73695974-T-C is described in ClinVar as Likely_benign. ClinVar VariationId is 261956.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| DNAL1 | NM_031427.4 | c.*32T>C | 3_prime_UTR_variant | Exon 8 of 8 | ENST00000553645.7 | NP_113615.2 | ||
| DNAL1 | NM_001201366.2 | c.*32T>C | 3_prime_UTR_variant | Exon 9 of 9 | NP_001188295.1 | |||
| DNAL1 | XM_017021679.3 | c.*32T>C | 3_prime_UTR_variant | Exon 9 of 9 | XP_016877168.1 | |||
| DNAL1 | XM_024449715.2 | c.*32T>C | 3_prime_UTR_variant | Exon 9 of 9 | XP_024305483.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| DNAL1 | ENST00000553645.7 | c.*32T>C | 3_prime_UTR_variant | Exon 8 of 8 | 1 | NM_031427.4 | ENSP00000452037.1 |
Frequencies
GnomAD3 genomes AF: 0.000184 AC: 28AN: 152244Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
28
AN:
152244
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000212 AC: 37AN: 174692 AF XY: 0.000291 show subpopulations
GnomAD2 exomes
AF:
AC:
37
AN:
174692
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000199 AC: 278AN: 1396036Hom.: 0 Cov.: 25 AF XY: 0.000220 AC XY: 152AN XY: 691154 show subpopulations
GnomAD4 exome
AF:
AC:
278
AN:
1396036
Hom.:
Cov.:
25
AF XY:
AC XY:
152
AN XY:
691154
show subpopulations
African (AFR)
AF:
AC:
3
AN:
31724
American (AMR)
AF:
AC:
5
AN:
37500
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25204
East Asian (EAS)
AF:
AC:
1
AN:
37150
South Asian (SAS)
AF:
AC:
11
AN:
78872
European-Finnish (FIN)
AF:
AC:
0
AN:
50368
Middle Eastern (MID)
AF:
AC:
14
AN:
5640
European-Non Finnish (NFE)
AF:
AC:
214
AN:
1071784
Other (OTH)
AF:
AC:
30
AN:
57794
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
11
22
34
45
56
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000184 AC: 28AN: 152362Hom.: 0 Cov.: 32 AF XY: 0.000228 AC XY: 17AN XY: 74518 show subpopulations
GnomAD4 genome
AF:
AC:
28
AN:
152362
Hom.:
Cov.:
32
AF XY:
AC XY:
17
AN XY:
74518
show subpopulations
African (AFR)
AF:
AC:
6
AN:
41602
American (AMR)
AF:
AC:
0
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
1
AN:
5194
South Asian (SAS)
AF:
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
AC:
20
AN:
68032
Other (OTH)
AF:
AC:
0
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3474
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.